Sales Expansion
First written in FY2016. 25 of 42 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2027-H1.
Nippon Shikizai moved to the "Worse" side of this theme in 2025, 1 year after the typical company in this theme (2024).
The whole theme swung hardest in 2025: 8 of 48 companies on the "Worse" side.
28 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Net sales increased 14.0% year on year to ¥9,155 million. This was despite delays in the launches of new products by domestic cosmetics manufacturers in response to the heightened tensions in the Middle East and the postponement of some large orders from overseas cosmetics manufacturers. Orders for pharmaceuticals and cosmetics at the French consolidated subsidiary remained firm, and the weaker yen also contributed.」
Although domestic orders were slowing and being postponed, interim net sales increased 14.0% year on year, supported by firm European orders and the weaker yen. - 2026-10-13AdvancedEarnings
「Net sales increased 14.0% year on year to ¥9,155 million. This was despite delays in the launches of new products by domestic cosmetics manufacturers in response to the heightened tensions in the Middle East and the postponement of some large orders from overseas cosmetics manufacturers. Orders for pharmaceuticals and cosmetics at the French consolidated subsidiary remained firm, and the weaker yen also contributed.」
一部受注の延期・先送りがある中でも、欧州受注と円安効果により中間期売上高は前年同期比14.0％増となった。 - 2026-10-08Worseneds.kabutan.jp
「７日の取引終了後に２７年２月期の連結業績予想について、売上高を１８３億６１００万円から１８３億２８００万円（前期比１０．１％増）へ、営業利益を３億９４００万円から２億６１００万円（同４５．０％増）へ、純利益を１億８７００万円から１億円（同７０．１％減）へ下方修正したことが嫌気されている。」
売上高の予想が下方修正され、売上拡大の見通しが従来より弱まった。 - FY2026WorsenedAnnual report
「Net sales for the consolidated fiscal year decreased by ¥989 million, or 5.6%, from the previous consolidated fiscal year to ¥16,643 million, due to the easing of the wave of new product orders and large orders in Japan following the end of the COVID-19 pandemic in the previous consolidated fiscal year, as well as sluggish orders for pharmaceuticals and cosmetics at the French consolidated subsidiary.」
The wave of new product and large orders seen in the previous fiscal year subsided, and full-year net sales declined 5.6% from the previous fiscal year. However, orders received were ¥17,514 million, equivalent to 111.9% of the previous fiscal year's level. - FY2026-H1WorsenedAnnual report
「Net sales amounted to ¥8,031 million, down 15.5% year on year, due to the easing of the wave of new product orders and large orders in Japan following the end of the COVID-19 pandemic in the previous consolidated fiscal year, as well as sluggish orders for pharmaceuticals and cosmetics at the French consolidated subsidiary.」
Net sales declined 15.5% year on year as the wave of new product orders and large orders subsided, while pharmaceutical and cosmetics orders in Europe remained sluggish. - FY2025-H1AdvancedAnnual report
「Net sales amounted to ¥9,505 million, up 29.2% year on year, due to increased orders from domestic and overseas manufacturers, including large orders, as cosmetics demand recovered following the end of the COVID-19 pandemic from the previous consolidated fiscal year, as well as the weaker yen.」
Net sales for the interim consolidated period rose 29.2% year on year, supported by increased orders from domestic and overseas manufacturers, including large orders. - FY2025-Q1AdvancedAnnual report
「Net sales amounted to ¥4,931 million, up 34.1% year on year, due to the recovery in domestic and overseas orders, including large orders, as cosmetics demand recovered following the substantial easing of the impact of COVID-19 from the previous consolidated fiscal year, as well as the weaker yen.」
First-quarter net sales rose 34.1% year on year, supported by the recovery in domestic and overseas orders, including large orders. - FY2024-Q3AdvancedAnnual report
「As domestic and overseas cosmetics demand continued to improve, orders for cosmetics and pharmaceuticals were recovering and increasing in both markets, and net sales amounted to ¥11,055 million, up 30.6% year on year.」
Against a backdrop of recovering domestic and overseas demand and orders, cumulative net sales for the first nine months amounted to ¥11,055 million, up 30.6% year on year. - FY2024-Q2AdvancedAnnual report
「As domestic and overseas cosmetics demand continued to improve, orders for cosmetics and pharmaceuticals were recovering and increasing in both markets, and net sales amounted to ¥7,355 million, up 31.1% year on year.」
Against a backdrop of recovering and increasing domestic and overseas demand and orders for cosmetics and pharmaceuticals, cumulative net sales for the first half rose 31.1% year on year. - FY2024-Q1AdvancedAnnual report
「Although orders remained below pre-pandemic levels, they were recovering in line with domestic and overseas cosmetics demand, and net sales amounted to ¥3,679 million, up 48.3% year on year.」
First-quarter net sales rose 48.3% year on year as domestic and overseas demand recovered. - FY2023AdvancedAnnual report
「Despite the continued substantial impact of COVID-19, net sales for the consolidated fiscal year increased by ¥3,058 million, or 35.1%, from the previous consolidated fiscal year to ¥11,760 million, due to the recovery in domestic and overseas orders accompanying signs of recovery in domestic and overseas cosmetics demand, as well as the addition of subsidiary Nippon Shikizai France S.A.S. to the scope of consolidation from the first quarter of the current consolidated fiscal year.」
Against a backdrop of recovering domestic and overseas cosmetics demand and orders and the inclusion of Nippon Shikizai France S.A.S. in the scope of consolidation, full-year net sales increased to ¥11,760 million. - FY2023-Q3AdvancedAnnual report
「Although revenue continued to be significantly affected by the COVID-19 pandemic, the recovery in orders from domestic and overseas customers, reflecting the recovery in domestic and overseas demand for cosmetics, together with the addition of subsidiary Nippon Shikizai France S.A.S. to the scope of consolidation from the first quarter, resulted in revenue of ¥8,468 million, up 32.5% year on year.」
Against a backdrop of recovering domestic and overseas cosmetics demand and orders and the inclusion of Nippon Shikizai France S.A.S. in the scope of consolidation, cumulative net sales for the first nine months rose 32.5% year on year. - FY2023-Q2AdvancedAnnual report
「Despite the continued substantial impact of COVID-19, net sales amounted to ¥5,612 million, up 28.9% year on year, due to the recovery in domestic and overseas orders accompanying signs of recovery in domestic and overseas cosmetics demand, as well as the addition of subsidiary Nippon Shikizai France S.A.S. to the scope of consolidation from the first quarter of the current consolidated fiscal year.」
Against a backdrop of recovering domestic and overseas demand and orders and the inclusion of Nippon Shikizai France S.A.S. in the scope of consolidation, cumulative net sales for the first half rose 28.9% year on year. - FY2023-Q1AdvancedAnnual report
「Net sales amounted to ¥2,481 million, up 18.8% year on year, due to signs of recovery in domestic and overseas cosmetics demand and orders, as well as the addition of subsidiary Nippon Shikizai France S.A.S. to the scope of consolidation from the first quarter of the current consolidated cumulative period.」
Signs of recovery emerged in domestic and overseas cosmetics demand and orders, and consolidated net sales rose 18.8% year on year. - FY2022Net sales declined, but orders received and order backlog increasedAnnual report
「Net sales decreased by ¥441 million, or 4.8%, from the previous consolidated fiscal year to ¥8,702 million.」
Full-year net sales declined 4.8% from the previous fiscal year, falling short of the sales growth target. Orders received and order backlog, however, increased. - FY2022-Q3WorsenedAnnual report
「Net sales amounted to ¥6,389 million, down 11.3% year on year, as the effects of ① sluggish consumer demand for makeup cosmetics amid calls to refrain from going out and the normalization of mask wearing as measures against COVID-19, ② the evaporation of inbound demand from visitors to Japan, and ③ sluggish orders for overseas markets due to the global spread of COVID-19 remained substantial, despite some recovery in repeat orders, while the French consolidated subsidiary also recorded lower sales during the first nine months of the current consolidated cumulative period due to the impact of COVID-19.」
Although some recovery in repeat orders was seen, net sales declined 11.3% year on year due to sluggish demand and overseas orders, postponed new product planning and lower sales at the French subsidiary. - FY2022-Q2WorsenedAnnual report
「Net sales amounted to ¥4,354 million, down 14.3% year on year, as the effects of ① lower consumer demand for makeup cosmetics resulting from calls to refrain from going out and the normalization of mask wearing as measures against COVID-19, ② a sharp decline in inbound demand from visitors to Japan, ③ decreased orders for products destined for overseas markets due to the global spread of COVID-19, and ④ the postponement of new product planning remained substantial in Japan, while the French consolidated subsidiary also recorded lower sales during the first half of the current consolidated cumulative period due to the impact of COVID-19.」
As lower demand and orders and postponed new product planning continued, cumulative net sales for the first half declined 14.3% year on year. - FY2022-Q1WorsenedAnnual report
「Net sales amounted to ¥2,088 million, down 14.5% year on year.」
Due to lower demand and orders resulting from COVID-19, postponed new product planning and lower sales at the French subsidiary, first-quarter net sales declined 14.5% year on year. - FY2021WorsenedAnnual report
「Consolidated net sales declined by ¥3,064 million, or 25.1%, from the previous consolidated fiscal year to ¥9,143 million, mainly due to ① lower consumer demand for makeup cosmetics resulting from calls to refrain from going out and the normalization of mask wearing as measures against COVID-19, ② a sharp decline in inbound demand from visitors to Japan, ③ decreased orders for products destined for overseas markets due to the global spread of COVID-19, and ④ the postponement of new product planning, although sales at the French consolidated subsidiary remained broadly flat.」
Due to lower demand, decreased orders for overseas markets and postponed new product planning, full-year net sales declined 25.1% from the previous fiscal year. - FY2021-Q3Net sales declined due to the pandemic and postponement of new product planningAnnual report
「Net sales amounted to ¥7,205 million, down 21.2% year on year, mainly due to ① lower consumer demand for makeup cosmetics resulting from calls to refrain from going out and the normalization of mask wearing as measures against COVID-19, ② lower inbound demand from visitors to Japan, ③ decreased orders for products destined for overseas markets due to the global spread of COVID-19, and ④ the postponement of new product planning, although the French consolidated subsidiary recorded higher sales.」
Net sales fell 21.2% year on year due to calls to refrain from going out, mask wearing, lower inbound demand, decreased orders for overseas markets and postponed new product planning. - FY2021-Q2Pandemic-related decline in net sales continuedAnnual report
「Although the French consolidated subsidiary recorded higher sales, net sales amounted to ¥5,081 million, down 16.7% year on year.」
Due to lower domestic and overseas demand and decreased orders from cosmetics manufacturers, cumulative net sales for the first half fell 16.7% year on year against the target of expanding sales. - FY2021-Q1Net sales declined due to the pandemicAnnual report
「Net sales amounted to ¥2,442 million, down 22.2% year on year, as the impact of ① lower domestic demand, including reduced inbound demand due to the state of emergency, calls for people to refrain from going out and a sharp decline in tourists, and lower outbound demand due to the global spread of COVID-19, which reduced orders from Japanese cosmetics manufacturers, and ② lower orders from major overseas cosmetics manufacturers due to the global spread of COVID-19 was substantial, although the French consolidated subsidiary recorded higher sales.」
Due to lower domestic and overseas demand and decreased orders from domestic and overseas cosmetics manufacturers, net sales fell 22.2% year on year against the target of expanding sales. - FY2020AdvancedAnnual report
「Net sales increased by ¥712 million, or 6.2%, from the previous consolidated fiscal year to ¥12,207 million.」
Full-year consolidated net sales amounted to ¥12,207 million, up 6.2% from the previous fiscal year. - FY2020-Q3AdvancedAnnual report
「Net sales amounted to ¥9,142 million, up 6.7% year on year, mainly due to ① solid orders associated with outsourcing by Japanese cosmetics manufacturers amid inbound and outbound demand in Japan, ② increased orders for made-in-Japan products from major overseas cosmetics manufacturers, and ③ steady sales at the French consolidated subsidiary.」
Supported by domestic and overseas orders and sales at the French subsidiary, cumulative net sales for the first nine months rose 6.7% year on year to ¥9,142 million. - FY2020-Q2AdvancedAnnual report
「Net sales amounted to ¥6,101 million, up 10.5% year on year, mainly due to ① increased orders accompanying the expansion of outsourcing by Japanese cosmetics manufacturers amid inbound and outbound demand in Japan, ② increased orders for made-in-Japan products from major overseas cosmetics manufacturers, and ③ steady sales at the French consolidated subsidiary.」
Supported by expanded outsourcing by Japanese manufacturers, increased orders from major overseas cosmetics manufacturers and sales at the French subsidiary, cumulative net sales for the first half rose 10.5% year on year to ¥6,101 million. - FY2020-Q1AdvancedAnnual report
「Net sales amounted to ¥3,141 million, up 19.5% year on year, mainly due to ① increased orders accompanying the expansion of outsourcing by Japanese cosmetics manufacturers amid inbound and outbound demand in Japan, ② increased orders for made-in-Japan products from major overseas cosmetics manufacturers, and ③ steady sales at the French consolidated subsidiary.」
Supported by expanded outsourcing by Japanese manufacturers, increased orders from major overseas cosmetics manufacturers and sales at the French subsidiary, consolidated net sales rose 19.5% year on year. - FY2019-Q3AdvancedAnnual report
「Net sales amounted to ¥8,565 million, up 8.0% year on year, mainly due to the capture of inbound and outbound demand in Japan, increased orders accompanying the expansion of outsourcing by Japanese cosmetics manufacturers, and steady sales at the French consolidated subsidiary.」
Supported by captured domestic and overseas demand, expanded outsourcing by Japanese cosmetics manufacturers and sales at the French subsidiary, cumulative net sales for the first nine months rose 8.0% year on year. - FY2019-Q2AdvancedAnnual report
「Net sales amounted to ¥5,521 million, up 3.3% year on year, mainly due to increased orders accompanying the expansion of outsourcing by Japanese cosmetics manufacturers, supported by inbound and outbound demand in Japan.」
Supported by captured inbound and outbound demand and expanded outsourcing by Japanese cosmetics manufacturers, cumulative net sales for the first half rose 3.3% year on year to ¥5,521 million. - FY2019-Q1AdvancedAnnual report
「Specifically, with the aim of expanding production capacity and sales, the company began considering implementation of the third-phase expansion of the Tsukuba Plant, the core project of its strategic growth investments, as well as」
As an initiative to expand production capacity and sales, the company began considering implementation of the third-phase expansion, and consolidated net sales for the first quarter of the current fiscal year amounted to ¥2,628 million, up 0.3% year on year. - FY2018AdvancedAnnual report
「Net sales amounted to ¥10,395 million, up 3.9% from the previous fiscal year, due mainly to increased orders from cosmetics manufacturers in Japan amid strong outsourcing demand and steady performance by the core pharmaceutical contract manufacturing business in France.」
Consolidated net sales amounted to ¥10,395 million, up 3.9% year on year, supported by increased domestic orders and the solid performance of the pharmaceutical contract manufacturing business in France. - FY2018-Q3AdvancedAnnual report
「Net sales for the first nine months of the current consolidated cumulative period amounted to ¥7,933 million, up 2.3% year on year.」
Consolidated net sales for the first nine months amounted to ¥7,933 million, up 2.3% year on year. - FY2018-Q2Exceeded plan, but net sales declined year on yearAnnual report
「Net sales for the first half of the current consolidated cumulative period exceeded the initial plan at ¥5,343 million, supported by the capture of inbound and outbound demand in Japan, a recovery in makeup products in the market, and strong orders for the French subsidiary's core pharmaceutical products, but declined 0.6% from the same period of the previous year.」
Net sales exceeded plan on the back of captured demand and pharmaceutical orders in France, but declined 0.6% year on year. - FY2018-Q1Net sales declined year on yearAnnual report
「Although neither net sales nor profit for the first quarter of the current consolidated cumulative period reached the level of the same period of the previous year, when inbound-related demand peaked, overall progress exceeded the initial outlook.」
Although the company continued proposal-based sales supported by innovative formulation development, net sales fell below the level of the same period of the previous year, when inbound-related demand peaked. - FY2017AdvancedAnnual report
「The Group will continue to promote proposal-based sales supported by innovative formulation development, work to strengthen its business base through sales growth, and」
By continuing innovative formulation development and proposal-based sales, consolidated net sales rose 14.9% year on year to ¥10,007 million. - FY2017-Q3AdvancedAnnual report
「Against this economic backdrop, the Group continued to promote proposal-based sales and work to expand sales, while also focusing on improving production efficiency. As a result, net sales for the first nine months of the current consolidated cumulative period amounted to ¥7,756 million, up 26.9% year on year.」
While continuing proposal-based sales and improving production efficiency, cumulative net sales for the first nine months amounted to ¥7,756 million, up 26.9% year on year. - FY2017-Q2AdvancedAnnual report
「Against this economic backdrop, the Group continued to promote proposal-based sales and focused on improving production efficiency. As a result, net sales for the first half of the current consolidated cumulative period amounted to ¥5,374 million, up 40.2% year on year.」
While continuing proposal-based sales and focusing on improving production efficiency, cumulative net sales increased 40.2% year on year. - FY2017-Q1AdvancedAnnual report
「The Group continued to promote proposal-based sales and worked to expand sales. As a result, net sales for the first quarter of the current consolidated cumulative period amounted to ¥2,645 million, up 43.7% year on year.」
While continuing proposal-based sales, first-quarter net sales increased 43.7% year on year. - FY2016First statedAnnual report
「By steadily implementing these initiatives, we will seek to expand revenue while reducing costs, with the aim of building a resilient earnings structure capable of generating recurring and stable profits.」
The company is targeting sales growth through initiatives including product development capabilities, production capacity and proposal-based sales.